Trakya University Researchers Report Research in Hyperalgesia (The therapeutic effects of transferring remote ischemic preconditioning serum in rats with neuropathic pain symptoms).

In rats that underwent partial sciatic nerve ligation, neuropathic pain symptoms developed on average on day 12 and persisted up to day 21 (p < 0.0001). Keywords: Acute-Phase Proteins; Beta-Globulins; Blood Proteins; Carrier Proteins; Drugs and Therapies; Health and Medicine; Hyperalgesia; Iron-Binding Proteins; Ischemic Preconditioning; Nervous System Diseases and Conditions; Neuroglia; Neurologic Manifestations; Neuropathic Pain; Neuropathy; Pain; Peripheral Nerves; Peripheral Nervous System; Proteins; Schwann Cells; Sensation Disorders; Somatosensory Disorders; Therapeutics; Therapy; Transferrin EN Acute-Phase Proteins Beta-Globulins Blood Proteins Carrier Proteins Drugs and Therapies Health and Medicine Hyperalgesia Iron-Binding Proteins Ischemic Preconditioning Nervous System Diseases and Conditions Neuroglia Neurologic Manifestations Neuropathic Pain Neuropathy Pain Peripheral Nerves Peripheral Nervous System Proteins Schwann Cells Sensation Disorders Somatosensory Disorders Therapeutics Therapy Transferrin 3423 3423 1 10/30/23 20231103 NES 231103 2023 NOV 3 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Research findings on hyperalgesia are discussed in a new report. [Extracted from the article]

Copyright of Drug Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)